Ultralife Corp (NASDAQ:ULBI) Q2 2025 Earnings Miss Estimates, Shares Plunge 20% in Pre-Market Trading

Ultralife Corp (NASDAQ:ULBI) reported its second-quarter earnings for 2025, missing analyst expectations on both revenue and earnings per share (EPS). The company’s financial performance, coupled with a sharp pre-market decline, reflects investor disappointment in the results.

Key Earnings Metrics vs. Estimates

• Revenue: Ultralife reported Q2 revenue of $48.56 million, falling short of the consensus estimate of $52.02 million. This represents a 6.7% miss against expectations.
• EPS: The company posted earnings of $0.07 per share, significantly below the estimated $0.1428, a 51% shortfall.

The weaker-than-expected results appear to have triggered a negative market reaction, with shares dropping over 20% in pre-market trading. This steep decline suggests investors were anticipating stronger performance, particularly given the company’s position in power solutions and communications systems.

Market Reaction & Recent Performance

The pre-market sell-off contrasts with the stock’s relatively stable performance in recent weeks:

• Last week: Flat (-0.006%)
• Last two weeks: Down 9.3%
• Last month: Down 6.7%

The sharp post-earnings drop indicates that the Q2 figures may have exacerbated existing concerns about the company’s near-term growth trajectory.

Analyst Expectations for Future Quarters

Looking ahead, analysts project the following for Ultralife:

• Q3 2025:
  • Revenue estimate: $54.06 million
  • EPS estimate: $0.224
• Full-year 2025:
  • Revenue estimate: $215.93 million
  • EPS estimate: $0.775

The company did not provide an explicit outlook in its press release, leaving investors to rely on external estimates. The absence of forward guidance does not necessarily signal weakness but may contribute to uncertainty amid the earnings miss.

Press Release Highlights

Ultralife’s earnings announcement primarily focused on the reported figures without additional commentary on operational developments or strategic updates. The lack of new business highlights or margin discussions may have further weighed on investor sentiment.

For a deeper dive into Ultralife’s earnings history and future estimates, review the earnings and estimates page.

Disclaimer: This article is not investment advice. Investors should conduct their own research or consult a financial advisor before making decisions.